PART II— Five Patent Invalidation Challenges- CSPC Succeeded in invalidating Mitsubishi Tanabe Pharma Corporation’s Novastan® HI injection 10 mg/2mL Patent – Lexology

PART II— Five Patent Invalidation Challenges- CSPC Succeeded in invalidating Mitsubishi Tanabe Pharma Corporation’s Novastan® HI injection 10 mg/2mL Patent  Lexology